THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, ...
The FDA said it would delay feedback on a diabetes drug developed by Lexicon previously expected by the end of the month, saying it needed more time to review data Lexicon submitted. The drug, called ...
A Southern rock legend with deep Florida roots will have a stretch of U.S. Highway 41 named after him — if the state approves. Sarasota County commissioners are sending a request to the Florida ...
Lexicon has pivoted back to a research-driven biotech model, abandoning internal drug marketing to focus on clinical development and out-licensing. Pilavapadin's upcoming Phase II readout is critical, ...
Investors might want to bet on Lexicon Pharmaceuticals (LXRX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Caltrans will close 20 miles of Highway 41 from June 9 to 13 for roadwork. Closure is part of major project to construct Cholame 'Y' interchange. Detours via Highway 33 may add up to 90 minutes of ...
LAS VEGAS — After a thrilling end to the first night, history was made on WrestleMania 41 Night 2. Three other championship matches took place, including the star-studded affair for the Women’s World ...
LAS VEGAS — The first night WWE’s grand spectacle ended in stunning fashion. WrestleMania 41 kicked off Saturday night as WWE brought the two-day event to Las Vegas. With plenty of drama and tension ...
THE WOODLANDS, Texas - Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), a biopharmaceutical company, will be participating in the 24th Annual Needham Virtual Healthcare Conference on April 9. The company ...
March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) climbed ~95% in the premarket trading on Friday after the Texas-based biotech announced an exclusive license agreement with Novo Nordisk (NVO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback